{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T04:42:50Z","timestamp":1791520970979,"version":"4.3.4"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,5,24]]},"DOI":"10.7759\/cureus.60975","type":"journal-article","created":{"date-parts":[[2024,5,24]],"date-time":"2024-05-24T08:45:36Z","timestamp":1716540336000},"source":"Crossref","is-referenced-by-count":4,"title":["Exploring Serum Vitamin D, Sex Hormones, and Lipid Profile Disparities in Women With and Without Polycystic Ovarian Syndrome: A Case-Control Study"],"prefix":"10.7759","author":[{"given":"Lateef A","family":"Akinola","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gideon N","family":"Inyangudo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abimbola T","family":"Ottun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayokunle M","family":"Olumodeji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adeniyi  A","family":"Adewunmi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Folasade  H","family":"Olalere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olufemi  M","family":"Omololu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Babalola D","family":"Ogungbemile","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","article-title":"Polycystic ovarian disease","author":"Rasquin LI","year":"2024","unstructured":"Rasquin LI, Anastasopoulou C, Mayrin JV. Polycystic ovarian disease. StatPearls [Internet]. StatPearls Publishing, Treasure Island (FL); 2024."},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1055\/s-0038-1668085","article-title":"A summary on polycystic ovary syndrome: diagnostic criteria, prevalence, clinical manifestations, and management according to the latest international guidelines","volume":"36","author":"Neven AC","year":"2018","unstructured":"Neven AC, Laven J, Teede HJ, Boyle JA. A summary on polycystic ovary syndrome: diagnostic criteria, prevalence, clinical manifestations, and management according to the latest international guidelines. Semin Reprod Med. 2018, 36:5-12. 10.1055\/s-0038-1668085","journal-title":"Semin Reprod Med"},{"key":"ref3","article-title":"A review: brief insight into polycystic ovarian syndrome","volume":"30","author":"Bulsara J","year":"2021","unstructured":"Bulsara J, Patel P, Soni A, Acharya S. A review: brief insight into polycystic ovarian syndrome. Endo Metab Sci. 2021, 30:100085.","journal-title":"Endo Metab Sci"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/deh098","article-title":"Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS)","volume":"19","year":"2004","unstructured":"Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod. 2004, 19.41-7. 10.1093\/humrep\/deh098","journal-title":"Hum Reprod"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.4103\/jhrs.JHRS_95_18","article-title":"The prevalence of polycystic ovary syndrome: a brief systematic review","volume":"13","author":"Deswal R","year":"2020","unstructured":"Deswal R, Narwal V, Dang A, Pundir CS. The prevalence of polycystic ovary syndrome: a brief systematic review. J Hum Reprod Sci. 2020, 13:261-71. 10.4103\/jhrs.JHRS_95_18","journal-title":"J Hum Reprod Sci"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.3390\/nu4030208","article-title":"Vitamin D and its role during pregnancy in attaining optimal health of mother and fetus","volume":"4","author":"Wagner CL","year":"2012","unstructured":"Wagner CL, Taylor SN, Dawodu A, Johnson DD, Hollis BW. Vitamin D and its role during pregnancy in attaining optimal health of mother and fetus. Nutrients. 2012, 4:208-30. 10.3390\/nu4030208","journal-title":"Nutrients"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.5935\/1518-0557.20240005","article-title":"Vitamin D and follicular recruitment in the in vitro fertilization cycle","volume":"28","author":"Antunes RA","year":"2024","unstructured":"Antunes RA, Melo BM, Souza MD, et al.. Vitamin D and follicular recruitment in the in vitro fertilization cycle. JBRA Assist Reprod. 2024, 28:269-75. 10.5935\/1518-0557.20240005","journal-title":"JBRA Assist Reprod"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.2012.04434.x","article-title":"Vitamin D in the aetiology and management of polycystic ovary syndrome","volume":"77","author":"Thomson RL","year":"2012","unstructured":"Thomson RL, Spedding S, Buckley JD. Vitamin D in the aetiology and management of polycystic ovary syndrome. Clin Endocrinol (Oxf). 2012, 77:343-50. 10.1111\/j.1365-2265.2012.04434.x","journal-title":"Clin Endocrinol (Oxf)"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.22159\/ajpcr.2019.v12i9.33310","article-title":"Role of VitD In etiopathogenesis and metabolic abnormalities seen in polycystic ovarian syndrome","volume":"12","author":"Sukul S","year":"2019","unstructured":"Sukul S, Bahinipati J, Das AK. Role of VitD In etiopathogenesis and metabolic abnormalities seen in polycystic ovarian syndrome. Asian J Pharm Clin Res. 2019, 12:215-9. 10.22159\/ajpcr.2019.v12i9.33310","journal-title":"Asian J Pharm Clin Res"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.18203\/2320-1770.ijrcog20230527","article-title":"Serum 25-OH VitD and insulin resistance in women with polycystic ovary syndrome","volume":"12","author":"Ansari A","year":"2023","unstructured":"Ansari A, Chandra S. Serum 25-OH VitD and insulin resistance in women with polycystic ovary syndrome. Int J Reprod Contracept Obstet Gynecol. 2023, 12:629-33. 10.18203\/2320-1770.ijrcog20230527","journal-title":"Int J Reprod Contracept Obstet Gynecol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.2478\/jomb-2018-0007","article-title":"Polymorphic variations in VDR gene in Saudi women with and without polycystic ovary syndrome (PCOS) and signi\ufb01cant in\ufb02uence of seven polymorphic sites on anthropometric and hormonal parameters","volume":"37","author":"Al Thomali A","year":"2018","unstructured":"Al Thomali A, Daghestani MH, Daghestani MH, Kaya N, Warsy A. Polymorphic variations in VDR gene in Saudi women with and without polycystic ovary syndrome (PCOS) and signi\ufb01cant in\ufb02uence of seven polymorphic sites on anthropometric and hormonal parameters. J Med Biochem. 2018, 37:415-25. 10.2478\/jomb-2018-0007","journal-title":"J Med Biochem"},{"key":"ref12","doi-asserted-by":"crossref","DOI":"10.1093\/clinchem\/18.6.499","article-title":"Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge","volume":"18","author":"Friedewald WT","year":"1972","unstructured":"Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972, 18:499-502.","journal-title":"Clin Chem"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2011-0385","article-title":"Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline","volume":"96","author":"Holick MF","year":"2011","unstructured":"Holick MF, Binkley NC, Bischoff-Ferrari HA, et al.. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2011, 96:1911-30. 10.1210\/jc.2011-0385","journal-title":"J Clin Endocrinol Metab"},{"key":"ref14","article-title":"Assessment of biochemical markers in polycystic ovarian syndrome patients in the Niger Delta region, Nigeria","volume":"4","author":"Ezeiruaku FC","year":"2022","unstructured":"Ezeiruaku FC, Onitsha EN. Assessment of biochemical markers in polycystic ovarian syndrome patients in the Niger Delta region, Nigeria. Eur J Med Health Sci. 2022, 4:100-10.","journal-title":"Eur J Med Health Sci"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2021.611351","article-title":"Low vitamin D level in Saudi women with polycystic ovary syndrome","volume":"8","author":"Bindayel IA","year":"2021","unstructured":"Bindayel IA. Low vitamin D level in Saudi women with polycystic ovary syndrome. Front Nutr. 2021, 8:611351. 10.3389\/fnut.2021.611351","journal-title":"Front Nutr"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.18203\/2320-1770.ijrcog20191231","article-title":"Waist hip ratio: an anatomical predictive marker of risk of PCOS","volume":"8","author":"Yadav S","year":"2019","unstructured":"Yadav S, Tarware R. Waist hip ratio: an anatomical predictive marker of risk of PCOS. Int J Reprod Contracept Obstet Gynecol. 2019, 8:1630-2. 10.18203\/2320-1770.ijrcog20191231","journal-title":"Int J Reprod Contracept Obstet Gynecol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.18203\/2320-1770.ijrcog20233634","article-title":"Study of lipid profile in polycystic ovarian syndrome: a case-control study in tertiary care hospital","volume":"12","author":"Marbaniang RS","year":"2023","unstructured":"Marbaniang RS, Singh YA, Kshetrimayum V, Naorem S, Laithangbam R, Ashem F. Study of lipid profile in polycystic ovarian syndrome: a case-control study in tertiary care hospital. Int Reprod Contracept Obstet Gynecol. 2023, 12:3561-6. 10.18203\/2320-1770.ijrcog20233634","journal-title":"Int Reprod Contracept Obstet Gynecol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsps.2023.03.021","article-title":"Association between insulin resistance and abnormal menstrual cycle in Saudi females with polycystic ovary syndrome","volume":"31","author":"Hussein K","year":"2023","unstructured":"Hussein K, Karami M. Association between insulin resistance and abnormal menstrual cycle in Saudi females with polycystic ovary syndrome. Saudi Pharm J. 2023, 31:1104-8. 10.1016\/j.jsps.2023.03.021","journal-title":"Saudi Pharm J"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.36648\/2386-5180.9.5.351","article-title":"Role of vitamin D in polycystic ovarian syndrome patients","volume":"9","author":"Kharb S","year":"2021","unstructured":"Kharb S, Gaur S, Aparna A, Rajni I, Nanda S. Role of vitamin D in polycystic ovarian syndrome patients. Annals of Clin Lab Res. 2021, 9:1-4. 10.36648\/2386-5180.9.5.351","journal-title":"Annals of Clin Lab Res"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.5653\/cerm.2014.41.2.80","article-title":"Vitamin D deficiency in women with polycystic ovary syndrome","volume":"41","author":"Kim JJ","year":"2014","unstructured":"Kim JJ, Choi YM, Chae SJ, et al.. Vitamin D deficiency in women with polycystic ovary syndrome. Clin Exp Reprod Med. 2014, 41:80-5. 10.5653\/cerm.2014.41.2.80","journal-title":"Clin Exp Reprod Med"},{"key":"ref21","article-title":"Is there any association between vitamin D levels and polycystic ovary syndrome (PCOS) phenotypes?","volume":"64","author":"Eftekhar M","year":"2020","unstructured":"Eftekhar M, Mirhashemi ES, Molaei B, Pourmasumi S. Is there any association between vitamin D levels and polycystic ovary syndrome (PCOS) phenotypes?. Arch Endocrinol Metab. 2020, 64:11-6.","journal-title":"Arch Endocrinol Metab"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.18502\/kme.v1i1.547","article-title":"VitD levels in women with polycystic ovary syndrome","volume":"125","author":"Elida S","year":"2016","unstructured":"Elida S, Binarwan H, Muhammad FG, Lutan D, Adenin I, Kaban Y. VitD levels in women with polycystic ovary syndrome. KNE Med. 2016, 125:88-95. 10.18502\/kme.v1i1.547","journal-title":"KNE Med"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.4103\/njm.njm_190_21","article-title":"Pattern of common hormonal disorders among patients with polycystic ovarian syndrome at a tertiary health facility in Nigeria","volume":"31","author":"Oladosu WO","year":"2022","unstructured":"Oladosu WO, Jimoh OS, Adeniyi WA, et al.. Pattern of common hormonal disorders among patients with polycystic ovarian syndrome at a tertiary health facility in Nigeria. Niger J Med. 2022, 31:92-7. 10.4103\/njm.njm_190_21","journal-title":"Niger J Med"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1007\/s10815-013-0149-0","article-title":"Diagnosis of polycystic ovary syndrome: AMH in combination with clinical symptoms","volume":"31","author":"Sahmay S","year":"2014","unstructured":"Sahmay S, Aydin Y, Oncul M, Senturk LM. Diagnosis of polycystic ovary syndrome: AMH in combination with clinical symptoms. J Assist Reprod Genet. 2014, 31:213-20. 10.1007\/s10815-013-0149-0","journal-title":"J Assist Reprod Genet"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.4236\/ojog.2018.813147","article-title":"Hormonal Imbalance in polycystic ovarian syndrome (PCOS) in Teaching Hospitals in Ekiti State. Nigeria","volume":"8","author":"Oyebanji OG","year":"2018","unstructured":"Oyebanji OG, Asaolu MF, Amonimo EO. Hormonal Imbalance in polycystic ovarian syndrome (PCOS) in Teaching Hospitals in Ekiti State. Nigeria. Open J Obstet Gynaecol. 2018, 8:1456-64. 10.4236\/ojog.2018.813147","journal-title":"Open J Obstet Gynaecol"},{"key":"ref26","article-title":"Identification of reference genes for qRT-PCR in granulosa cells of healthy women and polycystic ovarian syndrome patients","volume":"7","author":"Lv Y","year":"2017","unstructured":"Lv Y, Zhao SG, Lu G, et al.. Identification of reference genes for qRT-PCR in granulosa cells of healthy women and polycystic ovarian syndrome patients. Sci Rep. 2017, 7:6961.","journal-title":"Sci Rep"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygcen.2017.12.007","article-title":"Evaluation of different ranges of LH:FSH ratios in polycystic ovarian syndrome (PCOS) - clinical based case control study","volume":"260","author":"Malini NA","year":"2018","unstructured":"Malini NA, Roy George K. Evaluation of different ranges of LH:FSH ratios in polycystic ovarian syndrome (PCOS) - clinical based case control study. Gen Comp Endocrinol. 2018, 260:51-7. 10.1016\/j.ygcen.2017.12.007","journal-title":"Gen Comp Endocrinol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/246448-exploring-serum-vitamin-d-sex-hormones-and-lipid-profile-disparities-in-women-with-and-without-polycystic-ovarian-syndrome-a-case-control-study","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,24]],"date-time":"2024-05-24T08:45:45Z","timestamp":1716540345000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/246448-exploring-serum-vitamin-d-sex-hormones-and-lipid-profile-disparities-in-women-with-and-without-polycystic-ovarian-syndrome-a-case-control-study"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,24]]},"references-count":27,"URL":"https:\/\/doi.org\/10.7759\/cureus.60975","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5,24]]}}}